IPIC Message Board - Msg: 2544859

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC

IPIC 0.0001000

0.0%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Todd N. Weisrock who wrote (835)	10/24/1997 8:46:00 PM
From: WeirdPro Randy	Read Replies (1) of 1359

Todd, An interesting place to visit is the "diet pill" portion of the web page of the main lawfirm mentioned in the WSJ article at: rheingoldlaw.com It is interesting to see the bias they have towards AHP, and rightly so when one looks at the size of AHP, the prevalence of fen-phen prescriptions over Redux, and knowing that marketing was carried out by AHP almost exclusively. It is also interesting to note their concern over PPH,............ as a known risk of the fluramines, what is the problem? Certainly the companies reported on the increased prevalence of this disorder and is contained in prescribing literature HIGHLIGHTED IN BOLD PRINT......maybe a prescribing physician concern, but not the company's. Also an interesting resource is the PDR information on Redux accessed at: rxlist.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next